Treace Medical Concepts, Inc. (TMCI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 4.46 |
| Open | 4.43 |
| Day High | 4.54 |
| Day Low | 4.28 |
| 52-Week High | 7.78 |
| 52-Week Low | 1.17 |
| Volume | 252,756 |
| Average Volume | 696,280 |
| Market Cap | 281.55M |
| PE | -4.62 |
| EPS | -0.94 |
| Moving Average 50 Days | 4.34 |
| Moving Average 200 Days | 2.91 |
| Change | -0.12 |
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
GlobeNewswire Inc.
Feb 24, 2026 12:05 PM GMT
PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
GlobeNewswire Inc.
Feb 12, 2026 10:13 PM GMT
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
GlobeNewswire Inc.
Jan 13, 2026 12:05 PM GMT
PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor